Siena, Italy

Donatello Laera

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2017.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Donatello Laera: Innovator in Flow Cytometry Analysis

Introduction

Donatello Laera is a notable inventor based in Siena, Italy. He has made significant contributions to the field of flow cytometry, particularly in the analysis of materials adsorbed to metal salts. His innovative approach has the potential to enhance the understanding of various components in biological and chemical research.

Latest Patents

Laera holds a patent for his invention titled "Flow cytometry analysis of materials adsorbed to metal salts." This invention utilizes techniques and instruments typically used in flow cytometry as a tool for analyzing adsorbed materials. The method involves labeling the adsorbed component with a binding reagent and analyzing the labeled adsorbed component by flow cytometry. He has 1 patent to his name.

Career Highlights

Throughout his career, Donatello Laera has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with GlaxoSmithKline Biologicals and Novartis AG. His work in these organizations has allowed him to apply his expertise in flow cytometry and contribute to advancements in the field.

Collaborations

Laera has collaborated with several professionals in his field, including Sandra Nuti and Mildred Ugozzoli. These collaborations have likely enriched his research and development efforts, fostering innovation in flow cytometry analysis.

Conclusion

Donatello Laera's contributions to flow cytometry analysis demonstrate his commitment to advancing scientific knowledge. His innovative patent and collaborations with leading companies and professionals highlight his role as a significant inventor in this field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…